John Charles Kulli

7347838, Mar 25, 2008

Feb 5, 2005

10/906171

John C Kulli - Hamlin NY, US

Smiths Medical ASD, Inc. - Rockland MA

A61M 5/178

60416408

A needle tip protector () including a pair of apertured members ( or ) with spring arms () urging the apertured members ( or ) out of alignment to create a barrier to a needle tip (). A needle gripping U-shaped clip () may also provide a needle tip protector ().

7534227, May 19, 2009

Nov 21, 2006

11/562204

John C. Kulli - Hamlin NY, US

Smiths Medical ASD, Inc. - Rockland MA

A61M 5/178

60416408

A needle tip protector () including a pair of apertured members ( or ) with spring arms () urging the apertured members ( or ) out of alignment to create a barrier to a needle tip (). A needle gripping U-shaped clip () may also provide a needle tip protector ().

20060257323, Nov 16, 2006

Apr 19, 2006

11/406886

John Kulli - Hamlin NY, US

A61K 9/44
G06Q 50/00

424010200, 705002000

A drug-formulating method, a drug commercial-distribution method, and a drug formulation improve safety of a drug that is at risk for abuse—such as methylphenidate, or amphetamine, or an amphetamine-like central-nervous-system stimulant. The drug is formulated into a form (not a transdermal patch) that tends to deter conversion to powder; and in this form commercially distributed, e. g. wholesale or retail. Preferably that form is enclosed in a nontoxic capsule. Preferably the formulating includes dissolving or dispersing the drug into or onto a nontoxic carrier—for example a gel, e. g., methylcellulose, hydroxymethylcellulose, carbomer polymer, or other gelatinous pharmaceutical agent that is FDA-acceptable. Preferably the carrier is water-insoluble, to deter dissolving in water for injection. The carrier may be an oil or a solid—for example paper or other thin medium broadly extended in two dimensions, or a sponge or other medium having generally coarse cellular structure.

20070270753, Nov 22, 2007

Aug 6, 2007

11/834282

John Kulli - Hamlin NY, US

SMITHS MEDICAL ASD, INC. - Rockland MA

A61M 5/178

604164010

A needle tip protector () includes a needle gripping U-shaped clip ().

20080292665, Nov 27, 2008

May 25, 2007

11/807355

John C. Kulli - Hamlin NY, US

A61K 9/00

424400

Simple mechanical methods improve safety of a substance that is at risk for abuse. The substance is made in a specified form that tends to deter conversion to powder: and in this form commercially distributed, e.g. wholesale or retail. Preferably that form is enclosed in a harmless container. Preferably the method also includes putting the substance into or onto a harmless carrier. Preferably the carrier does not dissolve in. It may e oil or solid—for example paper or similarly thin medium, or a sponge or other medium that has generally course cellular structure.

49292412, May 29, 1990

Aug 5, 1988

7/228581

John C. Kulli - Pittsford NY

A61M 532

604263

A small protective guard rides on the shaft of a needle. After the needle has been inserted into a patient to deliver or withdraw fluids, the guard is positioned to form a protective barrier crossing in front of the needle tip. The guard is fashioned to collapse inward in front of the tip when its front portion is advanced past the needle tip. The guard carries sharp blades that engage the needle shaft and prevent the guard from moving forward off the needle once the device is activated. An optional manually operated trigger mechanism deploys the guard automatically.

49042424, Feb 27, 1990

May 31, 1988

7/200638

John C. Kulli - Pittsford NY

A61M 532

604110

A hollow needle projects from the forward end of a needle holder. The needle has a permanently attached ferrule, which is circumferentially grooved. The holder includes a handle to be grasped by a user, a frontal leaved structure for gripping the needle ferrule at its groove, and a rearward skirt for guarding the rear end of the needle. The rear of the needle is accessible within the skirt for attachment to vacuum vials, or to tubing for conducting liquid from the patient to a remote storage vessel. After use to withdraw liquid from a patient, the needle is released from the handle and retracted. The release and retraction are manually actuated by a simple unitary rectilinear motion. Preferably the mechanism for initiating release and retraction includes a separate safety container that is inserted into the rear skirt of the holder in the same manner as a vacuum vial, but that receives and encloses the entire needle for disposal. This separate safety container carries at its forward end a fitting for manipulating the frontal structure of the holder to spread the leaves, extracting them from the groove in the ferrule and thereby releasing the needle; and also a rearward-spring-biased retractor for engaging the needle and drawing it into the safety container.

20120301405, Nov 29, 2012

Jan 18, 2012

13/374844

John C. Kulli - Upper St. Clair PA, US

A61K 31/5513

424 101, 514221

A drug-formulating method, a drug commercial-distribution method, and a drug formulation improve safety of a drug that is at risk for abuse—such as methylphenidate, or amphetamine, or an amphetamine-like central-nervous-system stimulant, and particularly a benzodiazepine. The drug is formulated into a form (not a transdermal patch) that tends to deter conversion to powder; and in this form commercially distributed—preferably enclosed in, or dissolved or dispersed into or onto, a nontoxic carrier such as a capsule, for example a gel, e.g., methylcellulose, hydroxymethylcellulose, carbomer polymer, or other gelatinous pharmaceutical agent that is FDA-acceptable. The carrier is preferably water-insoluble, to deter dissolving in water for injection, and may be an oil or a solid—for example paper or other thin medium broadly extended in two dimensions, or a sponge or other medium having generally coarse cellular structure.